KLK3 and neoplasm: Thus, molecular characterization should not only quantitatively measure the number of circulating tumor cells (CTCs) in blood but also qualitatively characterize the “landscape” of these cells, for instance, by the expression of PSMA/PSA on the CTCs’ surface and tumor cell-associated mRNA.